SG/CALL/DERMAPHARM HOLDING/40/0.1/20.09.24 Stock

Warrant

DE000SW3XJT8

Delayed Deutsche Boerse AG 11:18:17 2024-07-08 EDT
0.09 EUR -25.00% Intraday chart for SG/CALL/DERMAPHARM HOLDING/40/0.1/20.09.24
Current month+30.43%
1 month-33.33%
Date Price Change
24-07-08 0.09 -25.00%
24-07-05 0.12 +33.33%
24-07-04 0.09 +8.43%
24-07-03 0.083 -7.78%
24-07-02 0.09 0.00%

Delayed Quote Deutsche Boerse AG

Last update July 08, 2024 at 11:18 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SW3XJT
ISINDE000SW3XJT8
Date issued 2023-09-25
Strike 40
Maturity 2024-09-20 (74 Days)
Parity 10 : 1
Emission price 0.61
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.046
Delta0.31x
Omega 10.94
Premium12.75x
Gearing35x
Moneyness 0.9100
Difference Strike 3.925
Difference Strike %+9.81%
Spread 0.012
Spread %10.91%
Intrinsic value 0.000000

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.1 EUR
Average target price
50.12 EUR
Spread / Average Target
+35.11%
Consensus